Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

microRNA-378a-5p iS a novel positive regulator of melanoma progression.

Tupone MG, D'Aguanno S, Di Martile M, Valentini E, Desideri M, Trisciuoglio D, Donzelli S, Sacconi A, Buglioni S, Ercolani C, Biagioni A, Fibbi G, Fattore L, Mancini R, Ciliberto G, Blandino G, Del Bufalo D.

Oncogenesis. 2020 Feb 14;9(2):22. doi: 10.1038/s41389-020-0203-6.

2.

Semaphorin 5A drives melanoma progression: role of Bcl-2, miR-204 and c-Myb.

D'Aguanno S, Valentini E, Tupone MG, Desideri M, Di Martile M, Spagnuolo M, Buglioni S, Ercolani C, Falcone I, De Dominici M, Milella M, Rizzo MG, Calabretta B, Cota C, Anichini A, Trisciuoglio D, Del Bufalo D.

J Exp Clin Cancer Res. 2018 Nov 19;37(1):278. doi: 10.1186/s13046-018-0933-x.

3.

Histone deacetylase inhibitor ITF2357 leads to apoptosis and enhances doxorubicin cytotoxicity in preclinical models of human sarcoma.

Di Martile M, Desideri M, Tupone MG, Buglioni S, Antoniani B, Mastroiorio C, Falcioni R, Ferraresi V, Baldini N, Biagini R, Milella M, Trisciuoglio D, Del Bufalo D.

Oncogenesis. 2018 Feb 23;7(2):20. doi: 10.1038/s41389-018-0026-x.

4.

BCL-XL overexpression promotes tumor progression-associated properties.

Trisciuoglio D, Tupone MG, Desideri M, Di Martile M, Gabellini C, Buglioni S, Pallocca M, Alessandrini G, D'Aguanno S, Del Bufalo D.

Cell Death Dis. 2017 Dec 13;8(12):3216. doi: 10.1038/s41419-017-0055-y.

5.

Small molecules targeted to the microtubule-Hec1 interaction inhibit cancer cell growth through microtubule stabilization.

Ferrara M, Sessa G, Fiore M, Bernard F, Asteriti IA, Cundari E, Colotti G, Ferla S, Desideri M, Buglioni S, Trisciuoglio D, Del Bufalo D, Brancale A, Degrassi F.

Oncogene. 2018 Jan 11;37(2):231-240. doi: 10.1038/onc.2017.320. Epub 2017 Sep 18.

6.

Caspase-8 contributes to angiogenesis and chemotherapy resistance in glioblastoma.

Fianco G, Mongiardi MP, Levi A, De Luca T, Desideri M, Trisciuoglio D, Del Bufalo D, Cinà I, Di Benedetto A, Mottolese M, Gentile A, Centonze D, Ferrè F, Barilà D.

Elife. 2017 Jun 8;6. pii: e22593. doi: 10.7554/eLife.22593.

7.

Histone acetyltransferase inhibitor CPTH6 preferentially targets lung cancer stem-like cells.

Di Martile M, Desideri M, De Luca T, Gabellini C, Buglioni S, Eramo A, Sette G, Milella M, Rotili D, Mai A, Carradori S, Secci D, De Maria R, Del Bufalo D, Trisciuoglio D.

Oncotarget. 2016 Mar 8;7(10):11332-48. doi: 10.18632/oncotarget.7238.

8.

Affinity purification-mass spectrometry analysis of bcl-2 interactome identified SLIRP as a novel interacting protein.

Trisciuoglio D, Desideri M, Farini V, De Luca T, Di Martile M, Tupone MG, Urbani A, D'Aguanno S, Del Bufalo D.

Cell Death Dis. 2016 Feb 11;7:e2090. doi: 10.1038/cddis.2015.357.

9.

NAADP-Dependent Ca(2+) Signaling Controls Melanoma Progression, Metastatic Dissemination and Neoangiogenesis.

Favia A, Pafumi I, Desideri M, Padula F, Montesano C, Passeri D, Nicoletti C, Orlandi A, Del Bufalo D, Sergi M, Ziparo E, Palombi F, Filippini A.

Sci Rep. 2016 Jan 6;6:18925. doi: 10.1038/srep18925.

10.

miR-211 and MITF modulation by Bcl-2 protein in melanoma cells.

De Luca T, Pelosi A, Trisciuoglio D, D'Aguanno S, Desideri M, Farini V, Di Martile M, Bellei B, Tupone MG, Candiloro A, Regazzo G, Rizzo MG, Del Bufalo D.

Mol Carcinog. 2016 Dec;55(12):2304-2312. doi: 10.1002/mc.22437. Epub 2015 Nov 24.

PMID:
26599548
11.

Venous Thromboembolism in Cancer: Frequently Asked Questions When Guidelines are Inconclusive.

Palla A, Celi A, Marconi L, Pistelli F, Tavanti L, Desideri M, Carrozzi L.

Cancer Invest. 2015 Apr;33(4):142-51. doi: 10.3109/07357907.2015.1009631. Epub 2015 Mar 17. Review.

PMID:
25781145
12.

TLR3 engagement induces IRF-3-dependent apoptosis in androgen-sensitive prostate cancer cells and inhibits tumour growth in vivo.

Gambara G, Desideri M, Stoppacciaro A, Padula F, De Cesaris P, Starace D, Tubaro A, Del Bufalo D, Filippini A, Ziparo E, Riccioli A.

J Cell Mol Med. 2015 Feb;19(2):327-39. doi: 10.1111/jcmm.12379. Epub 2014 Dec 2.

13.

VEGF-induced neoangiogenesis is mediated by NAADP and two-pore channel-2-dependent Ca2+ signaling.

Favia A, Desideri M, Gambara G, D'Alessio A, Ruas M, Esposito B, Del Bufalo D, Parrington J, Ziparo E, Palombi F, Galione A, Filippini A.

Proc Natl Acad Sci U S A. 2014 Nov 4;111(44):E4706-15. doi: 10.1073/pnas.1406029111. Epub 2014 Oct 20.

14.

Histone deacetylase inhibition synergistically enhances pemetrexed cytotoxicity through induction of apoptosis and autophagy in non-small cell lung cancer.

Del Bufalo D, Desideri M, De Luca T, Di Martile M, Gabellini C, Monica V, Busso S, Eramo A, De Maria R, Milella M, Trisciuoglio D.

Mol Cancer. 2014 Oct 9;13:230. doi: 10.1186/1476-4598-13-230.

15.

N-terminus-modified Hec1 suppresses tumour growth by interfering with kinetochore-microtubule dynamics.

Orticello M, Fiore M, Totta P, Desideri M, Barisic M, Passeri D, Lenzi J, Rosa A, Orlandi A, Maiato H, Del Bufalo D, Degrassi F.

Oncogene. 2015 Jun;34(25):3325-35. doi: 10.1038/onc.2014.265. Epub 2014 Aug 18.

PMID:
25132262
16.

Safety of fondaparinux in the prevention of venous thromboembolism in elderly medical patients: results of a single-center, retrospective study.

Silvestri F, Pasca S, Labombarda A, Barbi A, Desideri M, Guidi P, Rogato A, Zaramella M, Bergamo M, Ageno W, Barillari G.

Minerva Med. 2014 Jun;105(3):221-8.

PMID:
24988087
17.

BH4 domain of bcl-2 protein is required for its proangiogenic function under hypoxic condition.

Gabellini C, De Luca T, Trisciuoglio D, Desideri M, Di Martile M, Passeri D, Candiloro A, Biffoni M, Rizzo MG, Orlandi A, Del Bufalo D.

Carcinogenesis. 2013 Nov;34(11):2558-67. doi: 10.1093/carcin/bgt242. Epub 2013 Jul 8.

PMID:
23836782
18.

Papillary carcinoma of the thyroid: high expression of COX-2 and low expression of KAI-1/CD82 are associated with increased tumor invasiveness.

Scarpino S, Duranti E, Giglio S, Di Napoli A, Galafate D, Del Bufalo D, Desideri M, Socciarelli F, Stoppacciaro A, Ruco L.

Thyroid. 2013 Sep;23(9):1127-37. doi: 10.1089/thy.2011.0421. Epub 2013 Aug 27.

PMID:
23617728
19.

Removal of the BH4 domain from Bcl-2 protein triggers an autophagic process that impairs tumor growth.

Trisciuoglio D, De Luca T, Desideri M, Passeri D, Gabellini C, Scarpino S, Liang C, Orlandi A, Del Bufalo D.

Neoplasia. 2013 Mar;15(3):315-27.

20.

The thiazole derivative CPTH6 impairs autophagy.

Ragazzoni Y, Desideri M, Gabellini C, De Luca T, Carradori S, Secci D, Nescatelli R, Candiloro A, Condello M, Meschini S, Del Bufalo D, Trisciuoglio D.

Cell Death Dis. 2013 Mar 7;4:e524. doi: 10.1038/cddis.2013.53.

21.

LMNA knock-down affects differentiation and progression of human neuroblastoma cells.

Maresca G, Natoli M, Nardella M, Arisi I, Trisciuoglio D, Desideri M, Brandi R, D'Aguanno S, Nicotra MR, D'Onofrio M, Urbani A, Natali PG, Del Bufalo D, Felsani A, D'Agnano I.

PLoS One. 2012;7(9):e45513. doi: 10.1371/journal.pone.0045513. Epub 2012 Sep 26.

22.

Down-regulation of the PTTG1 proto-oncogene contributes to the melanoma suppressive effects of the cyclin-dependent kinase inhibitor PHA-848125.

Caporali S, Alvino E, Levati L, Esposito AI, Ciomei M, Brasca MG, Del Bufalo D, Desideri M, Bonmassar E, Pfeffer U, D'Atri S.

Biochem Pharmacol. 2012 Sep 1;84(5):598-611. doi: 10.1016/j.bcp.2012.06.004. Epub 2012 Jun 13.

PMID:
22704958
23.

The mitogen-activated protein kinase (MAPK) cascade controls phosphatase and tensin homolog (PTEN) expression through multiple mechanisms.

Ciuffreda L, Di Sanza C, Cesta Incani U, Eramo A, Desideri M, Biagioni F, Passeri D, Falcone I, Sette G, Bergamo P, Anichini A, Sabapathy K, McCubrey JA, Ricciardi MR, Tafuri A, Blandino G, Orlandi A, De Maria R, Cognetti F, Del Bufalo D, Milella M.

J Mol Med (Berl). 2012 Jun;90(6):667-79. doi: 10.1007/s00109-011-0844-1. Epub 2012 Jan 4.

PMID:
22215152
24.

CPTH6, a thiazole derivative, induces histone hypoacetylation and apoptosis in human leukemia cells.

Trisciuoglio D, Ragazzoni Y, Pelosi A, Desideri M, Carradori S, Gabellini C, Maresca G, Nescatelli R, Secci D, Bolasco A, Bizzarri B, Cavaliere C, D'Agnano I, Filetici P, Ricci-Vitiani L, Rizzo MG, Del Bufalo D.

Clin Cancer Res. 2012 Jan 15;18(2):475-86. doi: 10.1158/1078-0432.CCR-11-0579. Epub 2011 Nov 8.

25.

Involvement of BH4 domain of bcl-2 in the regulation of HIF-1-mediated VEGF expression in hypoxic tumor cells.

Trisciuoglio D, Gabellini C, Desideri M, Ragazzoni Y, De Luca T, Ziparo E, Del Bufalo D.

Cell Death Differ. 2011 Jun;18(6):1024-35. doi: 10.1038/cdd.2010.175. Epub 2011 Jan 14.

26.

Bcl-2 regulates HIF-1alpha protein stabilization in hypoxic melanoma cells via the molecular chaperone HSP90.

Trisciuoglio D, Gabellini C, Desideri M, Ziparo E, Zupi G, Del Bufalo D.

PLoS One. 2010 Jul 27;5(7):e11772. doi: 10.1371/journal.pone.0011772.

27.

Functional activity of CXCL8 receptors, CXCR1 and CXCR2, on human malignant melanoma progression.

Gabellini C, Trisciuoglio D, Desideri M, Candiloro A, Ragazzoni Y, Orlandi A, Zupi G, Del Bufalo D.

Eur J Cancer. 2009 Sep;45(14):2618-27. doi: 10.1016/j.ejca.2009.07.007. Epub 2009 Aug 13.

PMID:
19683430
28.

Growth-inhibitory and antiangiogenic activity of the MEK inhibitor PD0325901 in malignant melanoma with or without BRAF mutations.

Ciuffreda L, Del Bufalo D, Desideri M, Di Sanza C, Stoppacciaro A, Ricciardi MR, Chiaretti S, Tavolaro S, Benassi B, Bellacosa A, Foà R, Tafuri A, Cognetti F, Anichini A, Zupi G, Milella M.

Neoplasia. 2009 Aug;11(8):720-31.

29.

Modulation of bcl-xL in tumor cells regulates angiogenesis through CXCL8 expression.

Giorgini S, Trisciuoglio D, Gabellini C, Desideri M, Castellini L, Colarossi C, Zangemeister-Wittke U, Zupi G, Del Bufalo D.

Mol Cancer Res. 2007 Aug;5(8):761-71.

30.

Antiangiogenic potential of the Mammalian target of rapamycin inhibitor temsirolimus.

Del Bufalo D, Ciuffreda L, Trisciuoglio D, Desideri M, Cognetti F, Zupi G, Milella M.

Cancer Res. 2006 Jun 1;66(11):5549-54.

31.

Elective surgery for giant bullous emphysema: a 5-year clinical and functional follow-up.

Palla A, Desideri M, Rossi G, Bardi G, Mazzantini D, Mussi A, Giuntini C.

Chest. 2005 Oct;128(4):2043-50.

PMID:
16236853
32.

Bcl-2 overexpression in melanoma cells increases tumor progression-associated properties and in vivo tumor growth.

Trisciuoglio D, Desideri M, Ciuffreda L, Mottolese M, Ribatti D, Vacca A, Del Rosso M, Marcocci L, Zupi G, Del Bufalo D.

J Cell Physiol. 2005 Dec;205(3):414-21.

PMID:
15920759
33.

Smoking reduction in smokers compliant to a smoking cessation trial with nicotine patch.

Fornai E, Desideri M, Pistelli F, Carrozzi L, Puntoni R, Avino S, Gustavsson G, Säwe U, Viegi G, Giuntini C.

Monaldi Arch Chest Dis. 2001 Feb;56(1):5-10.

PMID:
11407211
34.

Smoking cessation clinic: an Italian experience.

Carrozzi L, Pistelli F, Fornai E, Desideri M, Viegi G, Giuntini C.

Monaldi Arch Chest Dis. 2000 Dec;55(6):502-5. No abstract available.

PMID:
11272640
35.

Computerized impedance plethysmography in the diagnosis of delayed deep vein thrombosis after total hip replacement.

Pazzagli M, Mazzantini D, Desideri M, Palla A.

Monaldi Arch Chest Dis. 2000 Apr;55(2):106-9.

PMID:
10949868
36.

Nasal ventilation in COPD exacerbations: early and late results of a prospective, controlled study.

Bardi G, Pierotello R, Desideri M, Valdisserri L, Bottai M, Palla A.

Eur Respir J. 2000 Jan;15(1):98-104.

37.

[Treatment of pulmonary embolism].

Palla A, Balbarini A, Pazzagli M, Desideri M, Di Santo D.

Cardiologia. 1998 Jun;43 Suppl 1:73-7. Review. Italian. No abstract available.

PMID:
9780464
38.

Mortality rates for respiratory disorders in Italy (1979-1990).

Desideri M, Viegi G, Carrozzi L, Pedreschi M, Pistelli F, Maggiorelli F, Fornai E, Paoletti P, Giuntini C.

Monaldi Arch Chest Dis. 1997 Jun;52(3):212-6.

PMID:
9270243
39.

Evaluation of DNA damage in leukocytes of ex-smokers by single cell gel electrophoresis.

Frenzilli G, Betti C, Davini T, Desideri M, Fornai E, Giannessi L, Maggiorelli F, Paoletti P, Barale R.

Mutat Res. 1997 Apr 29;375(2):117-23.

PMID:
9202722
40.

[Clinico-tomographic contribution to the diagnosis of pregnancy-puerperal cerebral venous thrombosis].

Sinibaldi L, Tarroni P, Scarinci A, Desideri M.

Riv Neurobiol. 1980 Oct-Dec;26(4):441-52. Italian. No abstract available.

PMID:
7339855

Supplemental Content

Loading ...
Support Center